JournalsHub
.online
Find My Journal
AW

Andrea Wang‐Gillam

Washington University in St. Louis US

ORCID 0000-0003-0458-7614
430
Publications
15,287
Citations
48
H-Index
125
i10-Index
11.3
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models OA
Yu Zhu, Brett L. Knolhoff, Melissa A. Meyer, Timothy M. Nywening, Brian L. West +5 more
Cancer Research 2014
1,265
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky, Andrew Dean, Yan‐Shen Shan +76 more
The Lancet 2015
1,175
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy OA
Hong Jiang, Samarth Hegde, Brett L. Knolhoff, Yu Zhu, John M. Herndon +8 more
Nature Medicine 2016
1,015
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Jonathan B. Mitchem, Donal J. Brennan, Brett L. Knolhoff, Brian A. Belt, Yu Zhu +14 more
Cancer Research 2012
934
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis OA
Mustafa Suker, Berend R. Beumer, Eran Sadot, Lysiane Marthey, Jason E. Faris +15 more
The Lancet Oncology 2016
898

Publications

431 total

Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial

Yuankai Shi, Jian Fang, L. Xing, Yu Yao, Jian Zhang - Nature Medicine, 2025
Cited by 22 Semantic Scholar

Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials.

Jian Li, Zhenghang Wang, Jingjing Huang, Yi Ba, B. Cao - The Lancet Gastroenterology and Hepatology, 2025
Cited by 0 Semantic Scholar

Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial.

Jia Zhong, Jun Zhao, J. Duan, Jian Fang, K. Fei - The Lancet Respiratory Medicine, 2025
Cited by 1 Semantic Scholar

Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials

Jian Li, Ting Deng, Yanhong Gu, A. C. Blanco, Zhihua Li - Cancer Communications, 2025
Cited by 4 Semantic Scholar

Preliminary Results of Patients with Myelofibrosis (MF) from a Phase I Trial of Jab-8263, a Potent BET Inhibitor

Junyuan Qi, Bo Jiang, Wei Yang, Xudong Wei, Hongmei Jing - Blood, 2024
Cited by 0 Semantic Scholar

653O Glecirasib (KRAS G12C inhibitor) in combination with JAB-3312 (SHP2 inhibitor) in patients with KRAS p.G12C mutated solid tumors

J. Wang, J. Zhao, J. Zhong, X. Li, J. Fang - Annals of Oncology, 2023
Cited by 21 Semantic Scholar

Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma PDF

Davendra Sohal, Mai Duong, Syed A. Ahmad, Namita Gandhi, Muhammad Shaalan Beg et al. - JAMA Oncology, 2021
Cited by 291 OpenAlex

NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors PDF

Andrea Wang‐Gillam, Richard Hubner, Jens T. Siveke, Daniel D. Von Hoff, Bruce Belanger et al. - European Journal of Cancer, 2019
Cited by 310 OpenAlex

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis PDF

Quisette P. Janssen, Stefan Buettner, Mustafa Suker, Berend R. Beumer, Pietro Addeo et al. - JNCI Journal of the National Cancer Institute, 2019
Cited by 288 OpenAlex

Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study) PDF

Dung T. Le, Vincent J. Picozzi, Andrew H. Ko, Zev A. Wainberg, Hedy L. Kindler et al. - Clinical Cancer Research, 2019
Cited by 257 OpenAlex

Research Topics

Pancreatic and Hepatic Oncology Research (251) Cancer Immunotherapy and Biomarkers (99) Cancer Genomics and Diagnostics (91) Colorectal Cancer Treatments and Studies (55) Cancer Research and Treatments (54)

Frequent Co-Authors

DA
David G. DeNardo
5 joint publications
DA
David C. Linehan
4 joint publications
YU
Yu Zhu
3 joint publications
BR
Brett L. Knolhoff
3 joint publications
TI
Timothy M. Nywening
3 joint publications
S.
S. Peter Goedegebuure
3 joint publications

Affiliations

University of North Carolina at Chapel Hill
US 2024 - 2024
American Cancer Society
US 2020 - 2020
Dartmouth–Hitchcock Medical Center
US 2021 - 2021
Barnes-Jewish Hospital
US 2024 - 2014
Cleveland Clinic
US 2019 - 2004

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now